Coronavirus
To visit the Select Subcommittee on the Coronavirus Crisis, click here.
In light of the ongoing Coronavirus crisis, the Committee on Oversight and Reform has been conducting oversight of our nation's preparedness for, and response to, the outbreak. The Committee's top priority is promoting the health and safety of the American people, and the information below is from the Committee's investigative activities, the Centers for Disease Control and Prevention (CDC), and other sources.
Oversight Committee Hearing Mentioned on NBC's Meet the Press, March 15, 2020:
Full Committee Activities:
More on Coronavirus
Washington, D.C. (July 27, 2021)—Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, released the following statement on updated mask guidance issued by the Centers for Disease Control and Prevention (CDC) today:
Washington, D.C. (July 22, 2021) —On Tuesday, July 27 at 10:30 a.m. ET, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, will hold a hybrid remote / in-person hearing on evictions during the coronavirus pandemic, the status of federal emergency rental assistance, and actions needed to prevent a housing crisis.
Washington, D.C. (July 20, 2021) — Yesterday, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, sent letters requesting documents and information from four corporate landlords with high eviction rates throughout the coronavirus pandemic.
Washington, D.C. (July 19, 2021) — Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, issued the following statement in response to a new report from the Government Accountability Office (GAO) regarding the nation's response to and recovery from the coronavirus pandemic:
Washington, D.C. (July 1, 2021) — Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, held a hearing with bipartisan witnesses on combating coronavirus vaccine hesitancy and increasing vaccinations across the country. During the hearing, witnesses and bipartisan Members of Congress encouraged all Americans to get vaccinated against the coronavirus.
Washington, D.C. (June 24, 2021)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, issued the following statement after Speaker Pelosi announced that a Select Committee would be established to investigate the January 6 attack on the Capitol:
"I applaud Speaker Pelosi's decision to establish a Select Committee to investigate the January 6 attack on the Capitol.
Washington, D.C. (June 23, 2021)— Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Rep. James E.
Washington, D.C. (June 22, 2021) — Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, held a hearing with Federal Reserve (Fed) Chair Jerome H.
Washington, D.C. (May 19, 2021) – Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, held a hybrid hearing with Emergent BioSolutions, Inc.'s (Emergent) President and Chief Executive Officer, Robert G. Kramer, and Executive Chairman, Fuad El-Hibri.
Washington, D.C. (May 19, 2021)—At today's Select Subcommittee on the Coronavirus Crisis hearing examining Emergent Biosolutions's multi-million-dollar contracts to produce vaccines, Oversight and Reform Committee Chairwoman Carolyn B. Maloney questioned Emergent's CEO Robert Kramer. Mr. Kramer admitted under questioning that the United States has been unable to use any coronavirus vaccines the company has produced due to contamination issues—despite the fact that the federal government has already paid Emergent more than $271 million. Mr.